Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Torti

Showing results (221-230 of 241) with videos related to

Pageof 25
Sort By:
Breast Cancer Research and Treatment|November 30, 2010
SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancerKathryn A Clausen, Kimberly R Blish, Charles E Birse, et al.
Cancer Research|July 1, 1986
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsyF M Torti, M M Bristow, B L Lum, et al.
The Prostate|February 16, 2005
Serum levels of phytanic acid are associated with prostate cancer riskJianfeng Xu, Todd Thornburg, Aubrey R Turner, et al.
Cell|November 13, 2004
Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen speciesCan G Pham, Concetta Bubici, Francesca Zazzeroni, et al.
Plos Computational Biology|February 7, 2017
Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling PerspectiveJulia Chifman, Seda Arat, Zhiyong Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1Li Li, Celia J Fang, James C Ryan, et al.
JACC. Cardiovascular Imaging|May 7, 2013
Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular diseaseBrandon C Drafts, Katie M Twomley, Ralph D'Agostino, et al.
Molecular Biology of the Cell|November 23, 2007
A human bone morphogenetic protein antagonist is down-regulated in renal cancerKimberly Rose Blish, Wei Wang, Mark C Willingham, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 15, 2008
Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritinLan G Coffman, Julie C Brown, David A Johnson, et al.
Oncogene|March 21, 2017
Iron addiction: a novel therapeutic target in ovarian cancerD Basuli, L Tesfay, Z Deng, et al.
Pageof 25

Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Breast Cancer Research and Treatment|November 30, 2010
SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancerKathryn A Clausen, Kimberly R Blish, Charles E Birse, et al.
Cancer Research|July 1, 1986
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsyF M Torti, M M Bristow, B L Lum, et al.
The Prostate|February 16, 2005
Serum levels of phytanic acid are associated with prostate cancer riskJianfeng Xu, Todd Thornburg, Aubrey R Turner, et al.
Cell|November 13, 2004
Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen speciesCan G Pham, Concetta Bubici, Francesca Zazzeroni, et al.
Plos Computational Biology|February 7, 2017
Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling PerspectiveJulia Chifman, Seda Arat, Zhiyong Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1Li Li, Celia J Fang, James C Ryan, et al.
JACC. Cardiovascular Imaging|May 7, 2013
Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular diseaseBrandon C Drafts, Katie M Twomley, Ralph D'Agostino, et al.
Molecular Biology of the Cell|November 23, 2007
A human bone morphogenetic protein antagonist is down-regulated in renal cancerKimberly Rose Blish, Wei Wang, Mark C Willingham, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 15, 2008
Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritinLan G Coffman, Julie C Brown, David A Johnson, et al.
Oncogene|March 21, 2017
Iron addiction: a novel therapeutic target in ovarian cancerD Basuli, L Tesfay, Z Deng, et al.
Pageof 25